Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 4
2011 1
2012 1
2014 2
2015 3
2016 4
2017 6
2018 9
2019 7
2020 12
2021 9
2022 11
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Estrogen receptors in endocrine disorders.
Filardi T, Townsend KL, Lappano R, Caprio M. Filardi T, et al. Front Endocrinol (Lausanne). 2023 Nov 1;14:1325371. doi: 10.3389/fendo.2023.1325371. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027157 Free PMC article. No abstract available.
MicroRNA Modulation by Dietary Supplements in Obesity.
Filardi T, Sabato C, Lubrano C, Santangelo C, Morano S, Lenzi A, Migliaccio S, Ferretti E, Catanzaro G. Filardi T, et al. Biomedicines. 2020 Nov 27;8(12):545. doi: 10.3390/biomedicines8120545. Biomedicines. 2020. PMID: 33261062 Free PMC article. Review.
Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.
Grieco M, Giorgi A, Gentile MC, d'Erme M, Morano S, Maras B, Filardi T. Grieco M, et al. Among authors: filardi t. Front Neurosci. 2019 Oct 18;13:1112. doi: 10.3389/fnins.2019.01112. eCollection 2019. Front Neurosci. 2019. PMID: 31680842 Free PMC article. Review.
Human cell-based anti-inflammatory effects of rosiglitazone.
Sottili M, Filardi T, Cantini G, Cosmi L, Morano S, Luconi M, Lenzi A, Crescioli C. Sottili M, et al. Among authors: filardi t. J Endocrinol Invest. 2022 Jan;45(1):105-114. doi: 10.1007/s40618-021-01621-5. Epub 2021 Jun 25. J Endocrinol Invest. 2022. PMID: 34170488
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
71 results